Clinical Trials in San Francisco

Showing 8181-8200 of 12,991 trials

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

NCT02556177

This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

ConcussionTraumatic Brain Injury

GE Healthcare477 participantsStarted Nov 2015

San Diego, California, United States • San Francisco, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPhase 4< 1 mile

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

NCT01842581

The purpose of the study is to evaluate if rifaximin alone or rifaximin plus lactulose delays the onset of hepatic encephalopathy (HE) in participants with cirrhosis who have had a previous episode of HE.

Hepatic EncephalopathyCirrhosis

Bausch Health Americas, Inc.222 participantsStarted Jan 2013

Phoenix, Arizona, United States • Coronado, California, United States • Fresno, California, United States +40 more locations

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

Find Trials by Condition in San Francisco

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Males, Antioxidants, and Infertility Trial

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion

Health Coaching for Positive Airway Pressure Adherence

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia